Latest Breaking News On - Kamran alam - Page 1 : comparemela.com

Smt Suvra Som & Anr vs Sri Partha Pratim Mitra & Anr on 3 January, 2024

Smt Suvra Som & Anr vs Sri Partha Pratim Mitra & Anr on 3 January, 2024
indiankanoon.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiankanoon.org Daily Mail and Mail on Sunday newspapers.

West bengalTamil naduPartha pratim mitra anrShampa sarkarSuhashini cranguli saraniSrihari hanumandas totalaVellaya pillaiPartha pratim mitraAnindita basuArvindbhai kalyanji bhanusaliSuhasini ganguly saraniSayani ahmedSusanta kumar samantaSounak mondalSaunak bhattacharjeeKamran alam

Trinity Capital Inc Provides $40 Million Term Loan to Taysha Gene Therapies

Trinity Capital Inc Provides $40 Million Term Loan to Taysha Gene Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIgor dacruzKamran alamPrnewswire trinity capital incUt southwestern gene therapy programTaysha gene therapies incExchange commissionTrinity capital incLife sciences at trinityTaysha gene therapiesSecurity agreementManaging directorLife sciencesChief financial officerTrinity capitalGene therapies

FY2024 EPS Estimates for Taysha Gene Therapies, Inc Cut by Analyst (NASDAQ:TSHA)

FY2024 EPS Estimates for Taysha Gene Therapies, Inc Cut by Analyst (NASDAQ:TSHA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Paulb manningKamran alamRobertw bairdNeedham companyTaysha gene therapies incCanaccord genuity groupQuantum private wealthCantor fitzgeraldDynamic advisor solutionsVirtu financialSecurities exchange commissionTaysha gene therapiesFree reportTaysha gene therapieGene therapiesExchange commission

Taysha Gene Therapies (NASDAQ:TSHA) PT Raised to $7 00

Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its target price boosted by Cantor Fitzgerald from $6.00 to $7.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Several other research firms also recently issued reports on TSHA. Needham & Company LLC […]

Kamran alamRobertw bairdTaysha gene therapies incVanguard group incRenaissance technologiesJpmorgan chase coCantor fitzgeraldSecurities exchange commissionCanaccord genuity groupNeedham companySwiss national bankTaysha gene therapiesFree reportGenuity groupTruist financialModerate buy

Taysha Gene Therapies, Inc (NASDAQ:TSHA) Q3 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Taysha Gene Therapies Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United kingdomUnited statesKristen kluskaKamran alamSukumar nagendranCanaccord genuitySean nolanWhitney ijemHayleigh collinsTaysha gene therapies incCantor fitzgeraldData monitoring committeeHead of corporate communicationsEuropean commissionSilicon valley bankExchange commission